Tom Allen - Representing Maine's First District
 
GET THE DETAILS:

Tom's Rx Drug Legislation

Tom's Rx Drug Studies

CRS Rx Drug Studies

Other Rx Drug Studies

Affordable Rx Drug Help

Latest Rx Drug News

"Why So Expensive?" on CBS News "60 Minutes"

Issue home
 
OTHER LINKS:

House Committee on Energy & Commerce (Democratic Staff)

House Committee on Government Reform (Democratic Staff)

Affordable Medicines Task Force

Center for Studying Health System Change

Institute for Health Care Research & Policy Georgetown University

Maine Consumers for Affordable Health Care

Maine Rx Express

Rx Drugs & Free Trade

Alliance for Retired Americans

Center for Policy Alternatives

Common Cause

Congress Watch

Families USA

National Committee to Preserve Social Security and Medicare

Public Citizen

The Commonwealth Fund

The Kaiser Family Foundation

 
Other :

Press releases & more





 

 


Prescription Drugs
Learn more about Tom's efforts to provide a prescription drug discount and benefit available to all Medicare beneficiaries.

Tom's Rx Drug Studies

PRINTER FRIENDLY TEXT popup window    email article to a friend popup window


Rx Drugs More Expensive in Maine than in Canada, Europe, and Japan, 6/15/01



Beginning in 1998, Tom has commissioned a series of investigations by the Minority Staff Special Investigations Division of the House Committee on Government Reform to examine the prices that uninsured Maine seniors pay for the medications their doctors prescribe. In July of that year, Tom released the findings of his first study which found that, on average, uninsured Maine seniors pay twice as much for their prescription drugs as the pharmaceutical companies charge their favored customers including insurance companies and bulk purchasers like the federal government for the Veterans Administration and the Medicaid program. In October of 1998, Tom released a second study which found that uninsured Maine seniors pay 72 percent more for their prescription drugs than consumers in Canada and 102 percent more than consumers in Mexico. Tom released a third study in November 1999 which found that pharmaceutical companies also charge substantially less for drugs prescribed for seniors when those same drugs are used to treat animals. A fourth study, released in April of 2000 documented pharmaceutical company price discrimination for drugs used to treat breast cancer. In June of 2001, Tom released his most recent study which found the Maine seniors pay substantially more for their medications than consumers in Canada, Europe and Japan.

To obtain PDF format copies of these reports, click on the links below. PDF documents require Adobe Acrobat Reader. If you do not have Adobe Acrobat Reader, to download it, click here


Tom has used these studies to advance the debate in Congress over adding a prescription drug benefit to Medicare and making prescription drugs more affordable through his bill, H.R. 1400, the Prescription Drug Fairness for Seniors Act. Tom's studies have also been replicated by other members of Congress in their districts around the country (the first study alone has now been done in over 100 congressional districts), all with similar findings.

Related Links
Rx Drugs More Expensive in ME than in Canada, Europe, and Japan (6/15/01) go there
Drug Companies Profit at the Expense of Maine Seniors (7/98) go there
Rx Drugs: An International Price Comparison (10/98) go there
Rx Drug Price Discrimination in ME: Manufacturer Prices Are Higher for Humans than Animals (1/00) go there
Pricing of Breast Cancer Drugs in ME: Breast Cancer Victims Face Discriminatory Prices (4/00) go there

 


 

 

30
27